AARTI PHARMALABS Board Approves Unaudited Financial Results and Interim Dividend for Q3 FY2026
Aarti Pharmalabs announced the unaudited financial results for the quarter and nine months ended December 31, 2025, following a Board meeting…
Embassy Developments Limited Monitoring Agency Report on Preferential Issue Proceeds Utilization up to Q3 FY26
Embassy Developments Limited has submitted the Monitoring Agency Report for the quarter ending December 31, 2025 (Q3FY26), prepared by CARE…
Gulf Oil Lubricants India Limited Board Declares Interim Dividend and Approves Q3 FY2025-26 Results
Gulf Oil Lubricants India Limited’s Board of Directors has approved the Unaudited Financial Results for the third quarter and nine…
Sterlite Technologies Limited Board Approves Issuance of Warrants to Promoter for Capital Raise
Sterlite Technologies Limited announced an upcoming Extra Ordinary General Meeting (EGM) scheduled for Wednesday, March 04, 2026, to seek…
AARTI PHARMALABS Board Approves Q3 FY26 Unaudited Results and Interim Dividend of ₹1.50 Per Share
The Board of Directors of Aarti Pharmalabs approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine…
Redington Limited Internal Restructuring Complete within Turkish Subsidiary Arena
Redington Limited announced the completion of an internal restructuring scheme involving its Turkish stepdown subsidiary, Arena. The…
Nykaa (FSN E-Commerce Ventures) Q3 FY26 Results Showcase 27% Revenue Growth and Record EBITDA Margin
FSN E-Commerce Ventures (Nykaa) reported a strong third quarter for FY26, achieving 27% year-on-year growth in net revenue, reaching INR 2,873…
Ceigall India Limited Secures ₹1,700 Crore Solar Power Project Development Contract
Ceigall India Limited has received a Letter of Award (LOA) from Rewa Ultra Mega Solar Limited for developing Unit 1 (220 MW) at Morena Solar…
Balu Forge Industries Allotment of 1 Million Equity Shares Following Warrant Conversion
Balu Forge Industries approved the allotment of 10,00,000 Equity Shares on February 9, 2026, resulting from the exercise of Convertible…
Aurobindo Pharma Board Approves Merger of Two Wholly Owned Subsidiaries
The Board of Directors of Aurobindo Pharma Limited has sanctioned a Scheme of Amalgamation involving two wholly owned subsidiaries: Auro…